BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16606771)

  • 1. Stroke and memory performance in elderly persons without dementia.
    Reitz C; Luchsinger JA; Tang MX; Manly J; Mayeux R
    Arch Neurol; 2006 Apr; 63(4):571-6. PubMed ID: 16606771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of smoking and time on cognitive function in the elderly without dementia.
    Reitz C; Luchsinger J; Tang MX; Mayeux R
    Neurology; 2005 Sep; 65(6):870-5. PubMed ID: 16186526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
    Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
    Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of prior stroke with cognitive function and cognitive impairment: a population-based study.
    Knopman DS; Roberts RO; Geda YE; Boeve BF; Pankratz VS; Cha RH; Tangalos EG; Ivnik RJ; Petersen RC
    Arch Neurol; 2009 May; 66(5):614-9. PubMed ID: 19433661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
    Mayeux R; Small SA; Tang M; Tycko B; Stern Y
    Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of plasma lipids and time on memory performance in healthy elderly without dementia.
    Reitz C; Luchsinger J; Tang MX; Manly J; Mayeux R
    Neurology; 2005 Apr; 64(8):1378-83. PubMed ID: 15851727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in cognitive and functional skills increases mortality risk in nondemented elderly.
    Schupf N; Tang MX; Albert SM; Costa R; Andrews H; Lee JH; Mayeux R
    Neurology; 2005 Oct; 65(8):1218-26. PubMed ID: 16247048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verbal and visuospatial deficits in dementia with Lewy bodies.
    Johnson DK; Morris JC; Galvin JE
    Neurology; 2005 Oct; 65(8):1232-8. PubMed ID: 16247050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
    Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
    Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
    Klages J; Fisk JD
    Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function is associated with the rate of cognitive decline in the elderly.
    Buchman AS; Tanne D; Boyle PA; Shah RC; Leurgans SE; Bennett DA
    Neurology; 2009 Sep; 73(12):920-7. PubMed ID: 19657107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
    Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
    Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trajectories of cognitive decline in different types of dementia.
    Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM
    Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of cognitive impairment in stroke/TIA patients over 3 years.
    Sachdev PS; Lipnicki DM; Crawford JD; Wen W; Brodaty H
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1324-30. PubMed ID: 24659793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.
    DeCarli C; Mungas D; Harvey D; Reed B; Weiner M; Chui H; Jagust W
    Neurology; 2004 Jul; 63(2):220-7. PubMed ID: 15277612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).
    Stephan BCM; Minett T; Muniz-Terrera G; Harrison SL; Matthews FE; Brayne C
    Age Ageing; 2017 Sep; 46(5):755-760. PubMed ID: 28203692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
    Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.
    Stephens S; Kenny RA; Rowan E; Allan L; Kalaria RN; Bradbury M; Ballard CG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1053-7. PubMed ID: 15481073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of cognitive trajectories in diverse older persons.
    Mungas D; Beckett L; Harvey D; Farias ST; Reed B; Carmichael O; Olichney J; Miller J; DeCarli C
    Psychol Aging; 2010 Sep; 25(3):606-19. PubMed ID: 20677882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.